Business process description for referral procedures
Submitted by Anonymous (not verified) on 22 April 2025 - 15:18
Business process description for referral procedures
Business process description for quality defect and non-compliance management
Submitted by Anonymous (not verified) on 22 April 2025 - 15:17
Business process description for quality defect and non-compliance management
Business process description for certificates of medicinal products
Submitted by Anonymous (not verified) on 22 April 2025 - 15:16
Business process description for certificates of medicinal products
Business process description for parallel distribution
Submitted by Anonymous (not verified) on 22 April 2025 - 15:15
Business process description for parallel distribution
Business process description for medical devices
Submitted by Anonymous (not verified) on 22 April 2025 - 15:15
Business process description for medical devices
Business process description for pharmacovigilance
Submitted by Anonymous (not verified) on 22 April 2025 - 15:14
Business process description for pharmacovigilance
Human medicines European public assessment report (EPAR): Evra, norelgestromin,ethinyl estradiol, Date of authorisation: 22/08/2002, Revision: 26, Status: Authorised
Submitted by Anonymous (not verified) on 22 April 2025 - 15:14
Human medicines European public assessment report (EPAR): Evra, norelgestromin,ethinyl estradiol, Date of authorisation: 22/08/2002, Revision: 26, Status: Authorised
Business process description for paediatric medicines development
Submitted by Anonymous (not verified) on 22 April 2025 - 15:13
Business process description for paediatric medicines development
Business process description for orphan status management
Submitted by Anonymous (not verified) on 22 April 2025 - 15:12
Business process description for orphan status management
Business process description for scientific meeting management
Submitted by Anonymous (not verified) on 22 April 2025 - 15:11
Business process description for scientific meeting management